Press Releases :: Avalo Therapeutics, Inc. (AVTX)

Sep 4, 2026 4:05 pm EDT

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Sep 3, 2026 7:00 am EDT

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Aug 6, 2026 7:00 am EDT

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Jul 22, 2026 7:00 am EDT

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference

Jul 7, 2026 7:00 am EDT

Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum

Jun 26, 2026 7:00 am EDT

Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes

Jun 23, 2026 7:00 am EDT

Avalo Therapeutics Appoints Ron Philip to Board of Directors

Jun 16, 2026 7:00 am EDT

Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody

May 22, 2026 4:01 pm EDT

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

May 13, 2026 7:00 am EDT

Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates